4Lyden P D. Thrombolysis for acute stoke[J]. Prog Cardiovasc Dis, 1999,42(3) : 175-183.
5Hantson L, De Weerdt W, De Keyser J, et al. The European Stroke Scale[J]. Stroke, 1994,25 ( 11 ) : 2215.
6Mahoney F I, Barthel D W. Functional evaluation: the Barthel index[J]. Md Med J,1965,14(1) :61-65.
7Rothroek J F, Hart R G. Antithrombotie therapy in cerebrovascular disease[J]. Ann Intern Med, 1991, 115 (11):885-895.
8Trouillas P, Nighoghossian N, Getenet J C, et al . Open trial of intravenous tissue plasminogne activator in acute carotid territory stroke, correlations of outcome with clinical and radiological data[J]. Stroke, 1996,27 (5) : 882-890.
9Bousen G, Vorstrup S, Bogousslavsky J. Thrombolysis for stroke-time for a consensus [J]. Cerebrovasc Dis, 1996, 6 (6):376-380.
10del Zopper G J,Higashida T R,Furlah A J, et al . PROACT: aphase II randomized trial of recombiant Pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J].Stroke,1998,29(1):4-11.
二级参考文献35
1The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333(5): 1580-1587.
2Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study(ECASS ).JAMA, 1995, 274 (5): 1017-1025.
3Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke:does it work? Stroke, 1992, 23(12): 1826-1839
4Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology, 1992, 42(5): 976-982
5Brott TG, Haley EC Jr, Levy DE, et al. Urgent therapy for stroke.Part Ⅱ. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke, 1992, 23(5): 632- 640
6Trouillas P, Nighoghossian N, Getenet JC, et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke,Correlations of outcome with clinical and radiological data. Stroke.1996, 27(5): 882-890
7Boysen G, Vorstrup S, Bogousslavsky J. Thrombolysis for stroketine for a consensus. Cerebrovasc Dis, 1996, 6(6): 376-380
8The National Institute of Neurological Disorders and Stroke (NINDS) rt - PA Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. Stroke,1997, 28(8): 1530-1540
9del Zopper GJ, Higashida RT, Furlah AJ, et al. PROACT: a phase Ⅱ randomized trial of recombinant Pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators.Prolyse in Acute Cerebral Thromboembolism. Stroke, 1998, 29(1 ):4-11.
10Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultra early thrombolytic therapy. AJNR Am J Neuroradiol, 1996, 17(1):79-85.
5Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002; 324:71-86.
6Mehta P. Aspirin in the prophylaxis of coronary artery disease. Curr Opin Cardioi,2002;17:552-558.
7Choi JH, Bateman BT, Mangla S, et al. Endovascular recanalization therapy in aeute isehemie stroke [J]. Stroke, 2006, 37:419-424.
8Pieniazek P, Musialek P, Motyl R, et al, Use of the Parody AntiEmboli System an transient subclavian steal for cerebral protection during emergent vertebral artery recanalization[J]. J Endovasc There, 2004, 11:511-516.
9Qureshi AI, Kirmani JF, Harris-Lane P, et al .Vertebral artery origin sent placement with distal protection: technical and clinical results[J].AJNR Am J Neuroradiol, 2006, 27:1140-1145.
10Wehrtlan C, Hand RA. Guidot CA. et al.Atherosclerotic occlusive extra cranial vertebral artery disease: indications for intervention,endovascular techniques, short - term and long-term result [J]. J Intervene Cardio, 2004, 17:219-232.
